Dr. Marshall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-341-7500Fax+1 585-341-7510- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1991 - 1994
- UMass ChanInternship, Internal Medicine, 1989 - 1990
- Harvard Medical SchoolClass of 1989
Certifications & Licensure
- NY State Medical License 1994 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Neurobiological Predictors of Huntington's Disease (PREDICT-HD) Start of enrollment: 2002 Aug 01
- Effects of Music Therapy on Huntington's Disease Start of enrollment: 2004 Jul 01
- Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis Start of enrollment: 2011 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsSafety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.Michael J Brownstein, Neal G. Simon, Jeffrey D. Long, Jon W. Yankey, Hilda T Maibach, Merit Cudkowicz, Christopher S. Coffey, Robin Conwit, Codrin Lungu, Karen E. Ande...> ;Journal of Clinical Medicine. 2020 Nov 16
- 11 citationsThe CLN3 Disease Staging System: A New Tool for Clinical Research in Batten DiseaseMargaux C. Masten, Justin D. Williams, Jennifer Vermilion, Heather R. Adams, Amy Vierhile, Alyssa T. Collins, Frederick J. Marshall, Erika F. Augustine, Jonathan W. Mink> ;Neurology. 2020 Jun 9
- 1 citationsA novel, hybrid, single- and multi-site clinical trial design for CLN3 disease, an ultra-rare lysosomal storage disorder:Heather R. Adams, Sara Defendorf, Amy Vierhile, Jonathan W. Mink, Frederick J. Marshall, Erika F. Augustine> ;Clinical Trials. 2019 Jun 11
- Join now to see all
Press Mentions
- URMC to Lead First Gene Therapy Study for Batten DiseaseNovember 3rd, 2021
- New Grants Will Accelerate Clinical Trials in Rare Neurological DisordersJune 26th, 2019
Professional Memberships
- Member
Hospital Affiliations
- Highland HospitalRochester, New York
- Strong Memorial Hospital of the University of RochesterRochester, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: